Clinical Trial Update: Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a stem cell mobilization regimen using ibuprofen, G-CSF, and plerixafor in patients with X-linked chronic granulomatous diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease X-linked

Drugs mentioned

• Filgrastim (filgrastim)
• Ibuprofen (IBUPROFEN)
• Mozobil (plerixafor)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Chronic Granulomatous Disease X-linked (X-CGD) | Phase 2 | Status: RECRUITING